- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05099705
Testing a Family Service Navigator Program for Low-resourced Families of Young Children With Autism Spectrum Disorder
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Meghan Burke, PhD
- Phone Number: 615-585-1420
- Email: meghan.burke@vanderbilt.edu
Study Locations
-
-
Illinois
-
Champaign, Illinois, United States, 61820
- Recruiting
- University of Illinois at Urbana-Champaign
-
Contact:
- Meghan M Burke
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
For the families in the clinical trial, there are the following inclusion and exclusion criteria:
Inclusion criteria:
- Be a parent who is in some way from a low-resourced community,
- Be the parent a child with autism between the ages of 3-5,
- Be age 18 or older,
- Want assistance with navigating service delivery systems,
- Be English speaking or Spanish-speaking,
- Be able to provide informed consent,
- Own a phone which can use the treatment support system (or be provided a phone from the Public Assistance Office or from the grant)
Exclusion criteria:
-Individuals who do not meet all inclusion criteria are by definition excluded.
For the navigators in the clinical trial, they must meet inclusion and exclusion criteria:
Inclusion Criteria:
- Agree to participate in the navigator training and become an navigator,
- Be a parent who is in some way from a low-resourced community,
- Be the parent a child with autism who is older than 5,
- Be age 18 or older, Be English speaking,
- Be able to provide informed consent,
- Own a phone which can use the treatment support system (or be provided a phone from the Public Assistance Office or from the grant)
Exclusion criteria:
-Individuals who do not meet all inclusion criteria are by definition excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention Group (Access to an FSN/TSS)
40 participants will be randomly assigned to the intervention group (i.e., to receive an FSN and have access to the TSS).
The FSN may meet with the participant at least twice and provide navigation support.
|
An RCT will be conducted.
40 participants will be randomly assigned to the intervention group and 15 participants to the non-personalized comparison group (i.e., information, training, and referral).
The intervention group will have access to a navigator and the treatment support system.
|
No Intervention: Control Group (Access to Information, training and referral)
15 participants will be randomly assigned to the non-personalized comparison group (i.e., information, training, and referral).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Knowledge at 9 months
Time Frame: At the pre-survey and at the nine-month survey
|
Called the Autism Knowledge Scale, a multi-item measure examining knowledge of autism services.
There are 24 items with higher scores indicating more knowledge.
Scale ranges from 0-24.
|
At the pre-survey and at the nine-month survey
|
Change in Skills at 9 months
Time Frame: At the pre-survey and at the nine-month survey
|
Called the Comfort with Advocacy Scale, A multi-item measure examining skills to identify, access, and receive services.
There are 12 items with higher scores indicating greater advocacy.
Scale ranges from 0 to 60.
|
At the pre-survey and at the nine-month survey
|
Change in Advocacy at 9 months
Time Frame: At the pre-survey and at the nine-month survey
|
Called the Advocacy Skills Scale, a multi-item measure examining the frequency of advocacy activities.
There are nine items with higher scores indicating greater advocacy.
Scale ranges from 9 to 45.
|
At the pre-survey and at the nine-month survey
|
Change in Empowerment at 9 months
Time Frame: At the pre-survey and at the nine-month survey
|
Called the Family Empowerment Scale, aa multi-item measure examining empowerment in family, services, and community/political environments.
There are 34 items with higher scores indicating greater empowerment.
Scale ranges from 0 to 136.
|
At the pre-survey and at the nine-month survey
|
Change in Parenting self-efficacy at 9 months
Time Frame: At the pre-survey and at the nine-month survey
|
Called the Self-Efficacy scale, a multi-item measure examining competence in parenting.
There are nine items with higher scores indicating greater self-efficacy.
Scale ranges from 0 to 36.
|
At the pre-survey and at the nine-month survey
|
Change in Service Delivery Outcomes
Time Frame: At the pre-survey and at the three-month, six-month, and nine-month survey
|
Called the adapted service measure scale, access to the type, number, and quality of services and unmet service needs.
There are over 20 services with higher scores indicating needing greater services.
Scale ranges from 0 to 20.
|
At the pre-survey and at the three-month, six-month, and nine-month survey
|
Change in Adaptive and maladaptive behavior at 9 months
Time Frame: At the pre-survey and at the nine-month survey
|
Called the Vineland Adaptive Behavior Scale, a multi-item measure examining adaptive and maladaptive behavior.
There are 100 items with higher scores indicating greater adaptive behavior.
Scale ranges from 0 to 100.
|
At the pre-survey and at the nine-month survey
|
Change in Social responsiveness at 9 months
Time Frame: At the pre-survey and at the nine-month survey
|
Called the Social Responsiveness Scale, a multi-item measure to examine social responsiveness.
There are sixty items with higher scores indicating greater social responsiveness.
Scale ranges from 0 to 180.
|
At the pre-survey and at the nine-month survey
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Meghan Burke, PhD, Vanderbilt University
Publications and helpful links
General Publications
- Magana, S., et al., Use of promotoras de salud in interventions with Latino families of children with IDD. International Review of Research in Developmental Disabilities, 2014. 47: p. 39-75
- Burke, M.M. and S.E. Goldman, Special education advocacy among culturally and linguistically diverse families Journal of Research in Special Educational Needs 2018. 1: p. 3-14.
- Maas, C.J. and J.P. Hox, Sufficient sample sizes for multilevel modeling. Methodology, 2005. 1: p. 86- 92.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- University of Illinois
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
AbbVieRecruitingSchizophrenia | Bipolar I Disorder | Autism Spectrum Disorder (ASD)United States, Puerto Rico
Clinical Trials on Access to a Family Service Navigator and Treatment Support System
-
Hospices Civils de LyonCompletedNutrition DisordersFrance
-
The University of Hong KongCompleted
-
University of Western Ontario, CanadaCanadian Institutes of Health Research (CIHR); Children's Hospital of Eastern...CompletedChild Behavior | Behavior Problems | Sleep ProblemsCanada
-
Columbia UniversityNational Institute on Drug Abuse (NIDA); University of Miami; Weill Medical College... and other collaboratorsCompletedHIV | Substance Abuse | AIDSPuerto Rico
-
The National Center on Addiction and Substance...Patient-Centered Outcomes Research Institute; Massachusetts General Hospital; Columbia University and other collaboratorsNot yet recruitingSubstance Use
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)CompletedSubstance AbuseUnited States
-
Rabin Medical CenterEu Fifth Framework ISTCompletedCross Infection | Community-Acquired InfectionGermany, Israel, Italy
-
Salmaniya Medical ComplexRecruiting
-
Boston Medical CenterNational Institute on Drug Abuse (NIDA); Emory University; Grady Health SystemCompletedHIV Infection | Pain | Drug DependenceUnited States
-
New York UniversityRecruitingHIV Infections | Opioid Use Disorder | OverdoseUnited States